$20.67+ Billion Hormonal Contraceptives Market by 2030: Youth Awareness Fuels Growth Among 15–24 Year-Olds

PORTLAND, OR, UNITED STATES, October 7, 2024 /EINPresswire.com/ -- The global hormonal contraceptives market is experiencing steady growth, with a projected value of $20.67 billion by 2030. As birth control methods that regulate the endocrine system, hormonal contraceptives are crucial in preventing unplanned pregnancies. Here’s a unique look at the market and its key drivers:

𝐆𝐞𝐭 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.alliedmarketresearch.com/request-sample/4574

Market Overview

• Valuation: $15.02 billion in 2020, expected to reach $20.67 billion by 2030.
• Growth Rate: The market is growing at a compound annual growth rate (CAGR) of 3.3% from 2021 to 2030.

Key Market Players
Prominent players driving competition in the hormonal contraceptive market include:
• Bayer AG
• Pfizer Inc.
• Merck & Co. Inc.
• Teva Pharmaceutical Industries
• Johnson & Johnson
• The Female Health Company

Types of Hormonal Contraceptives

There are two main categories of hormonal contraceptives:

1. Progestin-Only Contraceptives: Use progestin, a synthetic form of the hormone progesterone.
2. Combined Hormonal Contraceptives: Contain both estrogen and progestin, commonly found in pills, patches, and vaginal rings.

Market Segmentation

The market is divided based on product type, hormone type, age group, end-user, and region:

1. Product Type:
• Oral Contraceptive Pills: The dominant segment due to high availability and effectiveness.
• Injectable Birth Control: Growing popularity for long-term use.
• Vaginal Rings & Transdermal Patches: Gaining traction for their ease of use and lower side effects.

2. Hormone Type:
• Combined Hormonal Contraceptives: Leading the market due to better efficiency in preventing pregnancy.
• Progestin-Only Contraceptives: Used by women who cannot tolerate estrogen.

3. Age Group:
• 15–24 Years: The largest consumer segment due to increasing awareness and access to contraceptives.
• 25–34 Years: Significant users, especially for family planning and avoiding unintended pregnancies.

4. End-User:
• Households: The dominant segment, driven by the widespread use of oral contraceptives at home.
• Hospitals & Clinics: Used for guidance and administration of more specialized contraceptive methods.

5. Regional Analysis:
• North America: Leading the market due to high adoption rates, advanced healthcare infrastructure, and governmental support.
• Asia-Pacific: Expected to grow rapidly due to increasing awareness of contraception and expanding healthcare access.

Market Growth Drivers

• Increased Focus on Family Planning: Growing awareness about modern contraceptive methods.
• Rising Use of Oral Pills: Oral contraceptives remain the most popular method due to their high effectiveness.
• Government Initiatives: Programs aimed at reducing teenage pregnancies and providing affordable contraceptive solutions.

Restraints and Challenges
• Health Risks: Some users experience side effects, including blood clots and weight gain, which can deter usage.
• Social and Cultural Barriers: Lack of social acceptance, particularly in developing regions, can slow market penetration.
• Alternative Methods: Non-hormonal contraceptives and natural family planning methods pose competition.

𝐄𝐧𝐪𝐮𝐢𝐫𝐞 𝐁𝐞𝐟𝐨𝐫𝐞 𝐁𝐮𝐲𝐢𝐧𝐠: https://www.alliedmarketresearch.com/purchase-enquiry/4574

David Correa
Allied Market Research
+1 800-792-5285
email us here
Visit us on social media:
Facebook
Twitter